Results 51 to 60 of about 2,422 (164)

Prognostic value of clinical parameters and exosomal lncRNA NEAT1_1 in MEN1‐related non‐functioning pancreatic neuroendocrine tumors

Journal of Neuroendocrinology, Volume 37, Issue 8, August 2025.
Abstract Non‐functioning pancreatic neuroendocrine tumors (NF‐pNETs) significantly contribute to the premature death of multiple endocrine neoplasia type 1 (MEN1) patients. Reliable prognostic markers are not yet available. MicroRNAs (miRNA) and long‐non‐coding (lnc) RNAs, transported by extracellular vesicles, are emerging as new prognostic tools ...
Jerena Manoharan, Max Albers, Natalia Khizanishvili, Norman Krasser‐Gercke, Maxime Schmitt, Ioannis Mintziras, Sabine Wächter, Anja Rinke, Yutong Gao, Jörg W. Bartsch, Moritz Jesinghaus, Pietro Di Fazio, Detlef K. Bartsch   +12 more
wiley   +1 more source

De novo Gastrinoma: A Case Report

GE: Portuguese Journal of Gastroenterology, 2019
Gastrinomas are neuroendocrine tumors characterized by gastrin overexpression – 80% are sporadic and 20% are associated with multiple endocrine neoplasia type 1.
Arsénio Barbosa, Filipa Gomes, Luísa Fonseca, Tiago Maia, Jorge Almeida   +4 more
doaj   +1 more source

Pancreatic neuroendocrine tumors in children and adolescents—Data from the German MET studies (1997–2023)

Journal of Neuroendocrinology, Volume 37, Issue 8, August 2025.
Abstract Pancreatic neuroendocrine tumors (panNETs) are rare pediatric malignancies with age‐specific clinical and biological features. Data on their presentation, management, and outcomes remain limited. This retrospective study analyzed 28 pediatric panNET cases from the German Malignant Endocrine Tumor (MET) Registry enrolled between 1997 and 2024 ...
Katharina Karges, Marina Kunstreich, Ulrich‐Frank Pape, Jörg Fuchs, Christian Vokuhl, Michael Abele, Dominik T. Schneider, Ines B. Brecht, Constantin Lapa, Michael C. Frühwald, Peter Vorwerk, Antje Redlich, Michaela Kuhlen   +12 more
wiley   +1 more source

Zollinger-Ellison Syndrome: A Narrative Review of Clinical Presentation, Pathogenesis, Diagnosis and Modern Management Approaches [PDF]

Journal of Clinical and Diagnostic Research
Zollinger-Ellison Syndrome (ZES) is rare disorder which is caused by gastrin-secreting neuroendocrine tumours known as gastrinomas, primarily located in the duodenum or pancreas.
Jaideep Reddy, Raju Shinde, Khushbu Vaidya, Prithvansh Malhotra, Bhagyesh Sapkale   +4 more
doaj   +1 more source

Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines

Cancer Medicine, Volume 14, Issue 14, July 2025.
ABSTRACT Background Multimodality therapy incorporating a combination of cytoreductive surgery (CRS), intraperitoneal (IP) and systemic therapy continues to evolve for peritoneal carcinomatosis (PC) However, treatment and outcomes vary depending on tumor of origin.
Expert Panel Management of Peritoneal Carcinomatosis, Timothy Kennedy, Sareena Singh, Gerard Abood, Eric Christenson, Christopher J. Anker, Dmitriy Akselrod, Christopher L. Hallemeier, Krishan R. Jethwa, Ed Kim, Percy Lee, Eric D. Miller, Neil B. Newman, J. Eva Selfridge, Navesh Sharma, William Small Jr, Leila Tchelebi, Vonetta M. Williams, Suzanne Russo   +18 more
wiley   +1 more source

Evolution of clinical ideas about Zollinger-Ellison syndrome

Терапевтический архив, 2014
The paper gives the current views of the diagnosis and treatment of Zollinger-Ellison syndrome (ZES). It underlines the importance of including ZES in differential diagnosis in patient with frequently recurrent and standard-dose proton pump inhibitor ...
I V Maev, D N Andreev, Iu A Kucheriavyĭ, E V Barkalova   +3 more
doaj  

Sporadic duodenal macrogastrinoma: a rare case report

Acta Medica Lituanica, 2013
Gastrinomas are rare neuroendocrine tumors characterized by the secretion of gastrin, which causes hyperchlorhydria, thereby producing the Zollinger-Ellison syndrome. In most cases this syndrome manifests as severe peptic ulcer disease. We are presenting
Dainius Šimčikas, Eligijus Poškus, Juozas Stanaitis, Ernesta Rinkevičiūtė, Algirdas Edvardas Tamošiūnas, Kęstutis Strupas   +5 more
doaj   +1 more source

Zollinger–Ellison syndrome: modern aspects of diagnostics and treatment

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2014
The aim of review. To reflect modern concepts on clinic, diagnostics and treatment of Zollinger–Ellison syndrome (ZES).Key points. ZES is rare disease related to intragastric hyperacidity.
I. V. Mayev, D. N. Andreev, Yu. A. Kucheryavyy, D. T. Dicheva   +3 more
doaj  

Zollinger–Ellison syndrome in a 12-year-old child

Journal of Indian Association of Pediatric Surgeons, 2017
The syndrome described by Zollinger and Ellison in 1955 is a rare clinical entity which is even rarer in children. This report describes a 12-year-old boy who presented with refractory peptic ulcer disease which was finally diagnosed to be due to a ...
Abir Lal Nath, Nandita A Saxena, Bharati K Kulkarni, Shyam S Borwankar, Hemant N Lahoti, Sanjay N Oak   +5 more
doaj   +1 more source

Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome—over a decade of follow-up

World Journal of Surgical Oncology, 2019
Background Zollinger-Ellison syndrome (ZES) is a rare condition characterized by hypersecretion of gastrin by gastrinoma tumors leading to severe peptic ulcer disease with potential development of gastric carcinoid tumors.
Lynsey M. Daniels, Marian Khalili, William F. Morano, Michaela Simoncini, Beth C. Mapow, Andrea Leaf, Wilbur B. Bowne   +6 more
doaj   +1 more source